Active ingredient
Erenumab
4 finished FDA listings contain Erenumab as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- ERENUMAB
- Dosage forms
- Injection, Injection, Solution
- Routes
- Subcutaneous
- Manufacturers / labelers
- 1
- Strengths listed
- 140 mg/ml · 70 mg/ml
- Brand names in FDA listings
- Aimovig
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 2045613
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| BLA 761077 | AMGEN INC | 2018-05-17 | 4 |
Official labeling on DailyMed
- AIMOVIG (ERENUMAB-AOOE) INJECTION AIMOVIG (ERENUMAB-AOOE) INJECTION, SOLUTION [AMGEN, INC] · version 25 · 2026-07-17
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.